In a filing, Corbus Pharmaceuticals Holdings Inc revealed its Chief Executive Officer Cohen Yuval unloaded Company’s shares for reported $0.97 million on Jun 18 ’24. In the deal valued at $42.24 per share,22,938 shares were sold. As a result of this transaction, Cohen Yuval now holds 77,221 shares worth roughly $4.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Moran Sean F. sold 1,958 shares, generating $82,479 in total proceeds. Upon selling the shares at $42.12, the Chief Financial Officer now owns 48,605 shares.
Before that, Cohen Yuval sold 11,103 shares. Corbus Pharmaceuticals Holdings Inc shares valued at $510,963 were divested by the Chief Executive Officer at a price of $46.02 per share. As a result of the transaction, Cohen Yuval now holds 84,400 shares, worth roughly $4.47 million.
Wedbush initiated its Corbus Pharmaceuticals Holdings Inc [CRBP] rating to an Outperform in a research note published on July 30, 2024; the price target was $85. B. Riley Securities began covering CRBP with “Buy” recommendation on June 26, 2024. Oppenheimer maintained its rating on June 03, 2024. It rated CRBP as “an Outperform”.
Price Performance Review of CRBP
On Tuesday, Corbus Pharmaceuticals Holdings Inc [NASDAQ:CRBP] saw its stock jump 1.09% to $52.98. Over the last five days, the stock has gained 0.08%. Corbus Pharmaceuticals Holdings Inc shares have risen nearly 777.15% since the year began. Nevertheless, the stocks have risen 690.75% over the past one year. While a 52-week high of $61.90 was reached on 07/31/24, a 52-week low of $3.03 was recorded on 01/16/24. SMA at 50 days reached $51.45, while 200 days put it at $30.41.
Levels Of Support And Resistance For CRBP Stock
The 24-hour chart illustrates a support level at 51.97, which if violated will result in even more drops to 50.96. On the upside, there is a resistance level at 54.25. A further resistance level may holdings at 55.52. The Relative Strength Index (RSI) on the 14-day chart is 48.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.67%. Stochastics%K at 47.07% indicates the stock is a holding.
How much short interest is there in Corbus Pharmaceuticals Holdings Inc?
A steep rise in short interest was recorded in Corbus Pharmaceuticals Holdings Inc stocks on
The most recent change occurred on May 13, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $77 price target.
